Darunavir (Prezista)

Published August 09, 2006; Updated October 19, 2014
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-03-10
Selected References
10. Darunavir [package insert]. East Bridgewater, NJ: Tibotec Therapeutics.
11. de Meyer S, Vangeneugden T, van Baelen B, de Paepe E, van Marck H, Picchio G, Lefebvre E, de Béthune MP. Resistance profile of darunavir: combined 24-week results from the POWER trials. AIDS Res Hum Retroviruses. 2008 Mar;24(3):379-88.
12. Cahn P, Fourie J, Grinsztejn B, Hodder S, Molina JM, Ruxrungtham K, Workman C, Van De Casteele T, De Doncker P, Lathouwers E, Tomaka F. Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients. AIDS. 2011 Apr 24;25(7):929-39.